Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 07, 2014
The Board of Consort Medical plc, today announced that it has agreed terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals Limited for £230 million. The closing of the transaction, which is expected to occur in ...
read more
Friday, December 15, 2017
China Biologic announced that Shandong Taibang Biological Products has received the operating permit to commence plasma collection at its new branch collection facility.
read more
Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated to renal research, has announced the opening of a new office location in downtown Durham, N.C., and the expansion of its U.S. field-based ...
read more
Wednesday, February 15, 2017
Ligand Pharmaceuticals has announced the appointment of Christel Iffland, Ph.D. as a Vice President of Antibody Technologies.
read more
Thursday, October 05, 2023
Advent, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma ...
read more
Avid Bioservices Inc., a dedicated biologics contract development and manufacturing organization (CDMO), announced that it will serve as the commercial manufacturer for the humanized monoclonal antibody portion of ZYNLONTA™ (loncastuximab tesirine-...
read more
KBI Biopharma and Selexis SA, both JSR Life Sciences companies, announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).
read more
INTEGRA’s Australian distributor, BioTools, has partnered with SNP to support COVID-19 testing using the ASSIST PLUS pipetting robot, helping the laboratory team to increase sample processing capacity and fast track COVID-19 assay development while ...
read more
Thursday, January 03, 2013
AbbVie today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Wednesday, August 24, 2016
AMRI has entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers.
read more
LSNE Contract Manufacturing announced they have signed a manufacturing supply agreement with Selecta Biosciences.
read more
Wednesday, March 18, 2020
The FDA is issuing this guidance to provide a policy to help accelerate the availability of novel coronavirus tests developed by laboratories and commercial manufacturers during the public health emergency.
read more
Monday, September 25, 2023
Charles River Laboratories International, Inc. announced the opening of another RightSourceSM facility, and first in the United Kingdom, which will provide services to the Stevenage advanced therapies biocluster.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more